檢測三種變形桿菌診斷血清（OX2 OX19 OXK)

廣州健侖生物科技有限公司

我司長期供應(yīng)尼古?。商鎸帲z測試劑盒，違禁品檢測試劑盒，單卡檢測，3聯(lián)卡到12聯(lián)卡，可以自由組合，根據(jù)您的需求自由組合，*，性價(jià)比高，產(chǎn)品質(zhì)量很好。

保存要求：除了有特殊說明，免疫檢測產(chǎn)品應(yīng)保存在2-8°C

產(chǎn)品規(guī)格：2ml/瓶

保質(zhì)期：2年

本試劑盒主要用于對病菌細(xì)菌進(jìn)行檢測，利用快速玻片凝集檢測技術(shù)

利用快速玻片凝集和對流免疫電泳(CIE)鑒定流感嗜血桿菌

變形桿菌診斷血清 OX2型 2ml

檢測三種變形桿菌診斷血清（OX2 OX19 OXK)

檢測三種變形桿菌診斷血清（OX2 OX19 OXK)

我司還有很多種血清學(xué)診斷血清、血液檢測、免疫檢測產(chǎn)品、毒素檢測、凝集檢測、酶免檢測、層析檢測、免疫熒光檢測產(chǎn)品，。

（ MOB：楊永漢）

我司還提供其它進(jìn)口或國產(chǎn)試劑盒：登革熱、瘧疾、流感、A鏈球菌、合胞病毒、腮病毒、乙腦、寨卡、黃熱病、基孔肯雅熱、克錐蟲病、違禁品濫用、肺炎球菌、軍團(tuán)菌、化妝品檢測、食品安全檢測等試劑盒以及日本生研細(xì)菌分型診斷血清、德國SiFin診斷血清、丹麥SSI診斷血清等產(chǎn)品。

想了解更多的產(chǎn)品及服務(wù)請掃描下方二維碼：

【公司名稱】 廣州健侖生物科技有限公司
【市場部】    楊永漢

【】 
【騰訊  】 
【公司地址】 廣州清華科技園創(chuàng)新基地番禺石樓鎮(zhèn)創(chuàng)啟路63號(hào)二期2幢101-103

（）加強(qiáng)病原學(xué)監(jiān)測，作為判定醫(yī)院感染的基礎(chǔ)；（）加強(qiáng)耐藥性監(jiān)測，以指導(dǎo)合理使用抗生素；（）加強(qiáng)環(huán)境、器械等微生物學(xué)調(diào)查，以達(dá)到衛(wèi)生學(xué)指標(biāo)的要求；（）保證醫(yī)院內(nèi)消毒、滅菌的質(zhì)量；（）通過流行病學(xué)調(diào)查和細(xì)菌學(xué)分型試驗(yàn)，追蹤感染源并加以控制。（一）加強(qiáng)監(jiān)測臨床微生物科是醫(yī)院感染控制委員會(huì)的必然成員，微生物檢驗(yàn)在醫(yī)院感染的監(jiān)測中起重要作用。若在臨床微生物檢驗(yàn)中發(fā)現(xiàn)有醫(yī)院感染問題，要及時(shí)與醫(yī)院感染控制部門、病房醫(yī)師和護(hù)士長，并注意發(fā)展動(dòng)態(tài)。醫(yī)院感染中的一些特殊耐藥菌如GRE、MRSA、產(chǎn)ESBL腸桿菌科細(xì)菌等常通過交叉感染傳播，曲霉菌、軍團(tuán)菌等常在空調(diào)、供水系統(tǒng)、霧化裝置存在并導(dǎo)致感染，對可能攜帶這些致病菌的來源常規(guī)監(jiān)測并提醒臨床注意，通?？捎行ьA(yù)防傳播擴(kuò)散并節(jié)省大量抗感染費(fèi)用。（二）醫(yī)院感染的教育和培訓(xùn)臨床微生物科要參與對有關(guān)人員進(jìn)行醫(yī)院感染的教育和培訓(xùn)工作。如講解臨床微生物標(biāo)本的采集、保存、運(yùn)送的要求和注意事項(xiàng)，對標(biāo)本采集前要求病人應(yīng)該做些什么準(zhǔn)備，采集標(biāo)本應(yīng)選擇什么時(shí)機(jī)、什么部位，每天采幾次。
() Strengthen etiological monitoring as the basis for determining nosocomial infections; () Strengthen drug resistance monitoring to guide the rational use of antibiotics; () Strengthen microbiological investigations of the environment and equipment to meet the requirements of hygiene indicators; () Guarantee The quality of disinfection and sterilization in the hospital; () Through the epidemiological investigation and bacteriological typing tests, track the source of infection and control it. (1) Strengthening the monitoring of the clinical microbiology department is an indispensable member of the Hospital Infection Control Committee. Microbial testing plays an important role in the monitoring of nosocomial infections. If there is a problem of nosocomial infection in the clinical microbiological examination, contact the hospital infection control department, ward doctor and head nurse in time, and pay attention to the development. Some special resistant bacteria in nosocomial infections such as GRE, MRSA, and ESBL-producing enterobacteriaceae are often transmitted through cross-infection. Aspergillus, Legionella, etc. often exist in air-conditioners, water systems, atomizers and cause infections. The sources of these pathogens routinely monitor and alert clinical attention, and can generally prevent transmission spread and save a lot of anti-infective costs. (B) Hospital Infection Education and Training The Clinical Microbiology Department should participate in the education and training of hospital infections for relevant personnel. Such as explaining the requirements of clinical microbiological specimens collection, preservation, transportation and precautions, what patients should do before the collection of specimens to be prepared, what time should be selected specimens, what parts, several times a day